Chronic obstructive pulmonary disease, asthma, and mechanical ventilation are risk factors for dyspnea in patients with long COVID: A Japanese nationwide cohort study
Emiko Matsuyama(Keio University), Koichi Fukunaga(Keio University), Ayano Oashi(Keio University), Tatsuya Kusumoto(Keio University), Kengo Nagashima(Keio University Hospital), Tetsuo Tani(Keio University), Keeya Sunata(Keio University), Fumitake Saito(Eiju General Hospital), Keiko Ohgino(Keio University), Katsunori Masaki(Keio University), Hiroyuki Kokuto(Japan Anti Tuberculosis Association), Soichiro Ueda(Social Insurance Saitama Chuo Hospital), Mayuko Watase(Keio University), Hideki Terai(Kitasato Institute Hospital), Kazuhiro Minami(Urawa University), Takashi Yoshiyama(Japan Anti Tuberculosis Association), Rie Hagiwara(Urawa University), Kota Ishioka(Keio University), Saeko Takahashi(Saiseikai Central Hospital), Takanori Asakura(Keio University), Naoki Miyazaki(Keio University Hospital), Ho Namkoong(Keio University), Jun Miyata(Keio University), Morio Nakamura(Saiseikai Central Hospital), Shotaro Chubachi(Keio University), Ichiro Kawada(Keio University), Makoto Ishii(Nagoya University), Masayoshi Miyawaki(Keio University), Toshiki Iwasaki(Keio University Hospital), Yasunori Sato(Keio University)
Cited by 4
Related Papers
Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer
|Science Translational Medicine|2013|565
<i>In vitro</i> modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant <i>EGFR</i> mutants in non-small-cell lung cancer
|Oncotarget|2015|159
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
|Cancer Cell|2022|101
<i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
|Cancer Discovery|2024|98
Activation of Tumor-Cell STING Primes NK-Cell Therapy
|Cancer Immunology Research|2022|88